Ingalls & Snyder LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,380	Closed	-$616K	–	434
2021 Q2	$616K	Sell	7,380 -1,735	-19%	-$145K	0.03%	276
2021 Q1	$688K	Sell	9,115 -1,560	-15%	-$118K	0.03%	251
2020 Q4	$936K	Sell	10,675 -165	-2%	-$14.5K	0.05%	223
2020 Q3	$825K	Buy	+10,840	New	+$825K	0.06%	191